Company / Book Value per Share
Stoke Therapeutics, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$6.523
FY2025
5-year range
$3.475 / $6.523
FY2021-FY2025
Trend
+87.7%
vs FY2024
Sector context
#91 of 209
Health Care
What the data says
At $6.523, Stoke Therapeutics, Inc.'s book value per share ranks #91 of 209 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 6 years of decline, reaching $6.523.
Based on SEC 10-K filings.
$6.523 in FY2025 with a 5-year CAGR of -5.3%.
Improved from $4.687 to $6.523 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
#91 of 209 in Health CareTop 44% of 209This company $6.523 Sector average $189.406
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.3%, indicating a declining trend.
- In FY2025, book value per share increased 87.7% year-over-year.
- Ranks #91 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.523 | +87.7% |
| FY2024 | $3.475 | -25.9% |
| FY2023 | $4.687 | -20.6% |
| FY2022 | $5.901 | -0.4% |
| FY2021 | $5.928 | -30.6% |
| FY2020 | $8.543 | -31.6% |
| FY2019 | $12.488 | -91.6% |
| FY2018 | $148.122 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026